xuhanghang
Lv5
1140 积分
2021-01-12 加入
-
The Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Orally Dosed QY201, a Novel JAK1/TYK2 Inhibitor, in Chinese Healthy Subjects
6天前
已完结
-
Developments in FGFR and IDH inhibitors for cholangiocarcinoma therapy
13天前
已完结
-
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
29天前
已完结
-
Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small Cell Lung Cancer
29天前
已完结
-
Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4
1个月前
已完结
-
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
1个月前
已完结
-
Efficacy of somapacitan in treatment-fatigue adult patients with growth hormone deficiency previously treated with once-daily growth hormone injections: a 24-week randomized active-controlled trial
1个月前
已完结
-
Guidelines for treatment of onychomycosis
1个月前
已完结
-
Role of Posaconazole Drug in the Treatment of Invasive Fungal Disease: A Review
1个月前
已完结
-
"Unveiling Onychomycosis: Pathogenesis, Diagnosis, and Innovative Treatment Strategies"
1个月前
已完结